Open Access
Table II
Scoping review results − Gabapentinoids in the prevention of postoperative nausea and vomiting.
Study | Study type | Methodological score | Number of patients | Indication | Gabapentinoid | Conclusion |
---|---|---|---|---|---|---|
Jahromi et al. [12] | Double-blind RCT | 63.5/100 | 30 | Prevention of postoperative nausea and vomiting in maxillofacial trauma surgery | Single dose 300 mg gabapentin 1 hour prior to anesthesia | Significant reduction in early (<24 hours) nausea and vomiting following maxillofacial trauma surgery Treatment safe and cost effective |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.